Stay updated with breaking news from Shelly Guyer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
– Report details the company's dedication to healthcare for humanity through sustainable practices coupled with progress towards its mission – SAN FRANCISCO, March 15, 2022... | March 15, 2022
/PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today released its 2022 Environmental, Social and Governance (ESG) Report summarizing...
/PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today released its 2022 Environmental, Social and Governance (ESG) Report summarizing...
/PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced the appointment of Roxi Wen as its chief financial officer, effective...
Invitae (NVTA) Q1 2021 Earnings Call Transcript Motley Fool Transcribing © The Motley Fool Logo of jester cap with thought bubble. Invitae (NYSE: NVTA) Laura D'Angelo -- Head of Investor Relations Thank you, operator, and good afternoon, everyone. Thank you for joining us for our first-quarter 2021 results call. Joining us today are Sean George, our CEO; Shelly Guyer, our CFO; and Katherine Stueland, our chief commercial officer. As you listen to today's conference call, we encourage you to have our press release available, which includes our financial results, as well as...